WORK Medical Technology WOK
NASDAQ WOK
$2.02 -0.03 (-1.46%)
At close: Sep 9, 2026 · 4:00 PM EDT

WORK Medical Technology (WOK) Liabilities and Shareholders Equity (2023 - 2026)

WORK Medical Technology's (WOK) quarterly Liabilities and Shareholders Equity came in at $48.3 million in Q1 2026, up 39.17% on a YoY basis from $34.7 million in Q1 2025, and up 45.7% quarter-over-quarter from $33.2 million in Q3 2025.

Analysis

WORK Medical Technology (WOK) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

WORK Medical Technology (WOK) has reported Liabilities and Shareholders Equity for 4 consecutive years, with $48.3 million the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 39.17% year-over-year to $48.3 million; the trailing twelve-month figure through Mar 2026 stood at $152.4 million (changed N/A YoY), and the FY2025 full-year result was $33.2 million, down 8.54% from the prior year.
  • Liabilities and Shareholders Equity advanced to $48.3 million in Q1 2026 per WOK's latest filing, from $33.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $48.3 million in Q1 2026 and bottomed at $30.0 million in Q3 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $36.5 million across 4 years, with a median of $34.7 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity declined 8.54% in 2025, then surged 39.17% in 2026.
  • Over 4 years, Liabilities and Shareholders Equity stood at $30.0 million in 2023, then increased by 21.0% to $36.3 million in 2024, then declined by 8.54% to $33.2 million in 2025, then soared by 45.7% to $48.3 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $48.3 million, $33.2 million, and $34.7 million for Q1 2026, Q3 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Becton Dickinson 50.32 Bn 49.46 Bn 2.32 Bn 50.73 Bn
2 Medline 48.11 Bn 52.93 Bn 2.22 Bn 39.35 Bn
3 West Pharmaceutical Services 23.93 Bn 23.49 Bn 329.20 Mn 4.08 Bn
4 Baxter International 13.34 Bn 11.16 Bn 1.03 Bn 19.79 Bn
5 Stevanato Group S.p.A 6.21 Bn 6.11 Bn 100.91 Mn 3.04 Bn
6 Acme United 241.34 Mn 236.30 Mn 26.69 Mn 200.65 Mn
7 Rockwell Medical 31.74 Mn 6.94 Mn 3.24 Mn 56.53 Mn
8 Retractable Technologies 21.26 Mn -18.61 Mn 190,852.00 141.69 Mn
9 United Health Products 12.24 Mn 12.21 Mn - 247,985.00
10 WORK Medical Technology 2.18 Mn 2,354.06 Bn - 48,309.51 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 48.31 Mn
Sep 30, 2025 33.16 Mn
Mar 31, 2025 34.71 Mn
Sep 30, 2024 36.25 Mn
Sep 30, 2023 29.96 Mn